2013 ETA Guideline: Management of Subclinical Hypothyroidism.
about
Levothyroxine treatment of mild subclinical hypothyroidism: a review of potential risks and benefitsSubclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-AnalysisManagement of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantationRecent Advances in Autoimmune Thyroid DiseasesClinical Update in Aspects of the Management of Autoimmune Thyroid DiseasesSubclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis.Sub-Clinical Hypothyroidism and Its Association With Increased Cardiovascular Mortality: Call for ActionThe Effect of Early Substitution of Subclinical Hypothyroidism on Biochemical Blood Parameters and the Quality of Life.Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study.Latent Hypothyroidism in Adults.The thyroid gland in postmenopausal women: physiology and diseases.Effect of Thyroxin Treatment on Carotid Intima-Media Thickness (CIMT) Reduction in Patients with Subclinical Hypothyroidism (SCH): a Meta-Analysis of Clinical Trials2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children.Cardiovascular risk and quality of life in elderly people with mild thyroid hormone deficiencyThyroid function and age-related macular degeneration: a prospective population-based cohort study--the Rotterdam Study.Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality.Factors associated with growth disturbance at celiac disease diagnosis in children: a retrospective cohort study.The Effects of Six-Month L-Thyroxine Treatment on Cognitive Functions and Event-Related Brain Potentials in Children with Subclinical Hypothyroidism.Thyroid function and risk of type 2 diabetes: a population-based prospective cohort studyPlasma proteome and metabolome characterization of an experimental human thyrotoxicosis modelGuidance in Subclinical Hyperthyroidism and Subclinical Hypothyroidism: Are We Making Progress?The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism.The lipid-lowering effect of levothyroxine in patients with subclinical hypothyroidism: A systematic review and meta-analysis of randomized controlled trials.Study on Subclinical Hypothyroidism and its Association with Various Inflammatory Markers.Is Confirmed Elevation of the Serum TSH with Normal Concentrations of Circulating Thyroid Hormones Sufficient for the Diagnosis of Subclinical Hypothyroidism?Effect of steroid replacement on thyroid function and thyroid autoimmunity in Addison's disease with primary hypothyroidism.Major adverse cardiovascular and cerebral events in hypothyroid patients undergoing percutaneous coronary interventionPrevalence of hypothyroidism in diabetic kidney disease and effect of thyroid hormone replacement on estimate glomerular filtration rate.Thyroid Stimulating Hormone Is Increased in Hypertensive Patients with Obstructive Sleep Apnea.Prevalence of hypothyroidism in nondiabetic chronic kidney disease and effect of thyroxine replacement on estimated glomerular filtration rate.Prevalence of treated hypothyroidism in the community: Analysis from general practices in North-East England with implications for the United Kingdom.Risk factors for cardiovascular disease in subclinical hypothyroidism.Subclinical hypothyroidism in childhood - current knowledge and open issues.Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update.Hypothyroidism and the Heart.Physical performance in newly diagnosed hypothyroidism: a pilot study.Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer.Current recommendations in the management of hypothyroidism: developed from a statement by the British Thyroid Association ExecutiveThe Relationship between Subclinical Thyroid Disease and Cardiovascular Disease Risk Score in Koreans.Evaluation of Daily Blood Pressure Alteration in Subclinical Hypothyroidism.
P2860
Q26765262-E0591847-FE02-4AA5-94D5-02804067AFBCQ26798245-E38874CF-82FA-4E02-ADD4-FAB823275A2FQ26827226-C03E5CD1-390D-4E04-8984-3A24894AA711Q28073651-B17B82CE-7755-4CD1-97E4-139522E24354Q28075859-0788D7B7-C962-4792-AB09-9B4C9E2B7415Q30927999-2A78B955-6993-42E9-B0E6-4EDB61971161Q33647463-0AAB180B-2310-4CD3-BA48-BAFF4DE6D899Q33801053-CC578280-E461-4F16-B3F4-4C58090AF2A8Q33883216-C7448193-1363-4332-AA9E-B2CA06BD5E1BQ33899720-24FF8450-6F47-489B-8D0F-97ED61BC56B5Q33903507-0E0CBD42-FE2C-4AA8-A37B-67FD29BB2E47Q33918706-B3C81909-3CA2-4ABB-8005-EFDEF71BCF8FQ33944124-E54461AE-F791-4D30-9A2B-EFD7AA7B8814Q34299725-3877BE41-1A33-4581-B93E-9F3755422547Q35530361-1346BB43-C2AC-4926-8FD5-0E4787B8BAA7Q35662248-311D1E2D-0373-441F-BD0F-9FBF31E4A25FQ35800055-5EA33278-9AC5-475C-B99A-F4E7AF21AEB8Q36038803-8D2E09AA-3466-4998-BB81-D16A61CD9FEFQ36148822-52F85E1D-7FC0-4D1A-99F8-67EE1B4619B4Q36243862-EBE86659-3FB3-453F-9746-9205C8C6B8E3Q36261197-FB4DDD7D-419D-4FF2-98E6-51F31555A813Q36261211-50273BB3-8273-45D8-A027-52E2C0386589Q36322952-BC8A7FF1-5D19-4EFC-A40D-C18F94125D43Q36343406-130B6D87-B56D-4544-850D-F35370616780Q36472616-7E0DFC57-6F1C-4778-B1D8-E76DD6DE9B9AQ36687468-EC4DF4E9-2B23-4787-9438-4C37E3CE7D64Q36948898-1301D72C-E4E4-4163-B22C-F97887EE028EQ37409115-3CDB0C3E-D964-45F0-9E03-B6E90AA0490CQ37416446-22A3F3F6-E6B0-4501-9D9D-660ADEBB6B52Q37711275-D2AA4911-52C0-4335-8392-31C81D7F4BF0Q38637359-B1C898E1-8BDB-407A-8113-F3218D1D17A4Q38792570-461C0855-DE3B-47D2-ACA5-AD209C4E0426Q38882594-D823C501-212B-4250-8F98-80E019B725B3Q38886293-C4B210D0-0499-44B8-9AB7-9E8B7FDA89CEQ39455840-4CB2BCCA-EF4A-49B6-9566-B467F3D3A458Q40231394-BB21C985-4082-4895-8E2B-158CB266585DQ40414975-D3E5A2AE-508F-4228-AFDE-186925E01A1AQ41634990-33866BCD-A954-43F9-9A49-16CDCB96B55CQ41648925-2BCE0738-2853-414C-AA70-352A8A1CE98CQ41669750-840D965E-B03A-4F1D-887D-521F61D0C56E
P2860
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
@en
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
@nl
type
label
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
@en
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
@nl
prefLabel
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
@en
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
@nl
P2093
P2860
P50
P356
P1476
2013 ETA Guideline: Management of Subclinical Hypothyroidism.
@en
P2093
Georg Brabant
Jean-Louis Wemeau
Robin P Peeters
P2860
P304
P356
10.1159/000356507
P577
2013-11-27T00:00:00Z